Fishawack launches new website and introduces new structure for growth
The Fishawack Group has launched their new website, introducing the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative. The new site showcases the Group’s capabilities as well as providing news, careers, and contact information for the expanding group, complementing Fishawack’s active presence on LinkedIn and Twitter.
The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has launched their new website. The revitalized website introduces the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative, as well as providing news, careers, and contact information for the expanding group, complementing Fishawack’s active presence on LinkedIn and Twitter.
Fishawack Medical Communications partners with global and regional pharmaceutical, biotechnology, and medical device clients to develop and deliver services in the fields of medical communications, scientific engagement, publications, market access, strategic consultancy, and thought leader consultancy.
Fishawack Creative ensures maximum impact for a client from an extensive offering of state-of-the-art services, strategic planning, creative development, brand marketing, and tactical execution. Connecting strategy and creative is the key to brand success and the Fishawack Creative team have demonstrated the effectiveness of this approach on some of the largest brands in the global pharmaceutical marketplace.
“It is great to have a fresh website that showcases our capabilities and better reflects the dynamism of Fishawack as we collaborate with and integrate our new agencies,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “The new two-division structure provides clarity for our clients of the medical communications and creative offerings our expanding teams deliver across the globe.”
This content was provided by Avalere Health
Company Details
Latest Content from Avalere Health
Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs
Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient
As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.
Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the…
Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts…
The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of…
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech…
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.